Evidence map›Paper›PMID 37384616›Full record

ArticlePLOS digital health2023

FindZebra online search delving into rare disease case reports using natural language processing.

Valentin Liévin, Jonas Meinertz Hansen, Allan Lund, Deborah Elstein, Mads Emil Matthiesen, Kaisa Elomaa, Kaja Zarakowska, Iris Himmelhan, Jaco Botha, Hanne Borgeskov and 1 more

Abstract read
In one paragraph

Article in PLOS digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Co-Occurrence ofInternational journal of molecular sciences · 2025
    Article
  4. Obstacles to Early Diagnosis of Gaucher Disease.Therapeutics and clinical risk management · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valentin LiévinDTU Compute, Technical University of Denmark, Lyngby, Denmark.
Jonas Meinertz HansenFindZebra, Denmark.
Allan LundCentre Inherited Metabolic Diseases, Department of Clinical Genetics and Paediatrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen Ø, Denmark.
Deborah ElsteinIndependent consultant; Jerusalem, Israel.
Mads Emil MatthiesenFindZebra, Denmark.
Kaisa ElomaaTakeda Oy, Helsinki, Finland.
Kaja ZarakowskaTakeda Pharmaceuticals International AG, Zürich, Switzerland.
Iris HimmelhanTakeda Pharmaceuticals International AG, Zürich, Switzerland.
Jaco BothaTakeda Pharmaceuticals International AG, Zürich, Switzerland.
Hanne BorgeskovDepartment of Clinical Pharmacology, Aalborg University Hospital, Aalborg, Denmark.
Ole WintherDTU Compute, Technical University of Denmark, Lyngby, Denmark.ORCID https://orcid.org/0000-0002-1966-3205

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early diagnosis is crucial for well-being and life quality of the rare disease patient. Access to the most complete knowledge about diseases through intelligent user interfaces can play an important role in supporting the physician reaching the correct diagnosis. Case reports may offer information about heterogeneous phenotypes which often further complicate rare disease diagnosis. The rare disease search engine FindZebra.com is extended to also access case report abstracts extracted from PubMed for several diseases. A search index for each disease is built in Apache Solr adding age, sex and clinical features extracted using text segmentation to enhance the specificity of search. Clinical experts performed retrospective validation of the search engine, utilising real-world Outcomes Survey data on Gaucher and Fabry patients. Medical experts evaluated the search results as being clinically relevant for the Fabry patients and less clinically relevant for the Gaucher patients. The shortcomings for Gaucher patients mainly reflect a mismatch between the current understanding and treatment of the disease and how it is reported in PubMed, notably in the older case reports. In response to this observation, a filter for the publication date was added in the final version of the tool available from deep.findzebra.com/<disease> with <disease> = gaucher, fabry, hae (Hereditary angioedema).

Identifiers

PMID37384616
PMCPMC10309602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.